This graph shows a 3Q operating profit analysis. For each segment, the year-on-year operating profit increase or decrease is shown, broken down into business factors and external and special factors. Patent-related income of ¥7.8 billion recorded in the Industrial Business was a temporary factor increasing profit in 3Q last year. Comparison on a basis that excludes this temporary factor shows a year-on-year net profit increase of ¥500 million.
As to the business factors, the Office Business and Professional Print Business showed a decrease in profit when the foreign exchange impact is excluded. However, we are making efforts to heighten profitability, for instance by expanding sales of A3 color models, and particularly of high-speed products, in the office business unit, and by generating value-added proposals in the production print business unit. A later slide will give more detail on this point. With its favorable results in digital radiography (DR) for North America, the Healthcare Business posted increasing profit. The measuring instruments business unit continued its solid performance from the first half, so that the Industrial Business also posted a significant increase in profit.
The external and special factors include foreign exchange effects that increased profit by ¥3.4 billion. Expenses of ¥2.5 billion related to bio-healthcare business acquisitions and other costs, as well as upfront investment in new business, ended up among the negative factors.
Our core and growth business overall posted increasing profits, and we consider the Group as a whole to have recorded an increase in profits.
As to the business factors, the Office Business and Professional Print Business showed a decrease in profit when the foreign exchange impact is excluded. However, we are making efforts to heighten profitability, for instance by expanding sales of A3 color models, and particularly of high-speed products, in the office business unit, and by generating value-added proposals in the production print business unit. A later slide will give more detail on this point. With its favorable results in digital radiography (DR) for North America, the Healthcare Business posted increasing profit. The measuring instruments business unit continued its solid performance from the first half, so that the Industrial Business also posted a significant increase in profit.
The external and special factors include foreign exchange effects that increased profit by ¥3.4 billion. Expenses of ¥2.5 billion related to bio-healthcare business acquisitions and other costs, as well as upfront investment in new business, ended up among the negative factors.
Our core and growth business overall posted increasing profits, and we consider the Group as a whole to have recorded an increase in profits.